In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.
Ylenia IngrasciottaValeria BelleudiFrancesco TrottaAntonio AddisAndrea FontanaAlessandro ChinellatoValentina IentileDaniele Ugo TariGiuseppe RobertoMaurizio PastorelloSalvatore ScondottoPasquale CananziGiuseppe TraversaMarina DavoliMariangela RossiGianluca Trifirònull nullPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2020)
Switching between ESAs was frequent in both CKD and cancer patients. The number of cumulative transfusions and severity of disease seemed to affect the switch.
Keyphrases